BioAdaptives, Inc.
BDPT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $493 | $448 | $64 | $337 |
| - Cash | $137 | $61 | $25 | $83 |
| + Debt | $343 | $329 | $392 | $437 |
| Enterprise Value | $699 | $716 | $430 | $691 |
| Revenue | $13 | $29 | $17 | $20 |
| % Growth | -55.6% | 66.3% | -13.1% | – |
| Gross Profit | $4 | $11 | $7 | $10 |
| % Margin | 31.8% | 37.9% | 41.5% | 51.1% |
| EBITDA | -$582 | -$521 | -$544 | -$644 |
| % Margin | -4,595.1% | -1,823.9% | -3,167.2% | -3,256.5% |
| Net Income | -$899 | -$712 | -$896 | -$1,050 |
| % Margin | -7,096.1% | -2,492.6% | -5,216.6% | -5,309.5% |
| EPS Diluted | -0.11 | -0.12 | -1.27 | -4.67 |
| % Growth | 8.3% | 90.6% | 72.8% | – |
| Operating Cash Flow | -$250 | -$224 | -$227 | -$159 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$250 | -$224 | -$227 | -$159 |